PlainBillCongress, translated.Legislation. Context. Public interest.
H.R.1796 / 106th Congress

Medicare Chronic Disease Prescription Drug Benefit Act of 1999

Referred to the Subcommittee on Health and Environment.

Official summary

Version 00 · Introduced in House · May 13, 1999

Medicare Chronic Disease Prescription Drug Benefit Act of 1999 - Amends part B (Supplementary Medical Insurance) of title XVIII (Medicare) of the Social Security Act (SSA) to provide for Federal payments to a State non-Medicaid prescription drug benefit program on behalf of Medicare part B enrollees for certain prescription drugs (including insulin) and biological products for treatment of specified chronic conditions.Provides for the selection through competitive bidding of eligible providers of such prescription drugs and biological products (covered outpatient drugs) in a particular coverage area. Requires an eligible beneficiary not enrolled in a Medicare+Choice plan under Medicare part C (Medicare+Choice) to enroll with an eligible entity under this Act to be eligible to receive covered outpatient drugs under Medicare part B. Mandates appropriate outreach activities by the Secretary of Health and Human Services.Outlines cost-sharing requirements establishing an annual deductible of $250.00 and specified co-payments (with no co-payment for generic drugs). Allows the use of formularies, generic drug substitution, and other mechanisms to provide benefits economically.Directs the Secretary to: (1) establish a model for comprehensive educational programs to assure appropriate prescribing, dispensing, and use of such covered drugs; and (2) enter into an arrangement with the Institute of Medicine of the National Academy of Sciences for analysis of such new benefit and annual reports to the Secretary and Congress on its effectiveness in reducing demand for acute medical services, as well as its annual cost and resulting savings. Provides for appropriate funding for such analyses.Amends SSA title XIX (Medicaid) to provide for Medicaid coverage of the new Medicare part B prescription drug benefit cost-sharing for certain individuals who would be qualified Medicare beneficiaries but for their income which exceeds the level established by the State but is less than a certain percentage of the official poverty line for a family of the size involved.

Read the summary on Congress.gov
PlainBill analysis is coming later. This page presents official source data. We have not yet published a PlainBill explanation for this bill.

Who introduced it

Rep. Cardin, Benjamin L. [D-MD-3] · D–MD

Committees

  • Energy and Commerce Committee
  • Ways and Means Committee
13 cosponsorship records, including any withdrawals

Actions

A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.

  1. Referred to the Subcommittee on Health and Environment.

  2. Referred to the Subcommittee on Health.

  3. Sponsor introductory remarks on measure. (CR E968)

  4. Referred to the Committee on Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  5. Referred to the Committee on Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  6. Referred to the Committee on Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  7. Introduced in House

  8. Introduced in House

Bill text & related measures

Text links open the official source. We currently store references to these documents.

Related bills identified by Congress.gov

No related bills are listed in this snapshot. This does not establish whether the proposal has appeared in earlier Congresses.

Source last updated: Jun 3, 2026. Consult Congress.gov for the current record.

Explore the bill from different angles

Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.

Neutral evidence review

Objective

Analyze H.R.1796 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.

View full prompt & sources
Fairness and public impact

Progressive lens

Examine H.R.1796 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.

View full prompt & sources
Institutions and government scope

Conservative lens

Examine H.R.1796 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.

View full prompt & sources
Individual rights and government power

Liberty lens

Examine H.R.1796 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.

View full prompt & sources